Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
limn
/
Liminatus Pharma Ord Shs Class A
LIMN
Add to Watchlist
0.104
USD
+0.002
+1.76%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
4.66M
Market Cap
Loss
P/E TTM
Liminatus Pharma Ord Shs Class A
0.104
+0.002
+1.76%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
More Details of Company
Liminatus Pharma Ord Shs Class A Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Liminatus Pharma Ord Shs Class A
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sang-jin Daniel Lee
Mr. Sang-jin Daniel Lee
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong C. Yoo, Ph.D.
Dr. Byong C. Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Beom K. Choi
Mr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
FAQs
Who are the top five shareholders of Liminatus Pharma Ord Shs Class A?
The top five shareholders of Liminatus Pharma Ord Shs Class A are: Mr. Nicholas Fernandez